noscript

News and Announcements

Alcidion Appoint Resapp Health Co-Founder Brian Leedman

  • Published July 28, 2016 12:00AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

28th July 2016, ASX Announcement

Alcidion Group Limited (ASX: ALC), a global leader in Clinical Informatics, today announced the appointment of Mr. Brian Leedman to the bord of the Company. This move comes at a pivotal time for Alcidion as the Company looks to expand market share of their award-winning Miya Platform product internationally.

Mr. Leedman is  the co-founder of Resapp Health (ASX: RAP) where he currently serves in the role of the Executive Director and Vice President, Corporate Affairs. Mr Leedman is a marketing and investor relations professional with over 10 years’ experience in the biotechnology / healthcare industry. Prior to Resapp Helath, Mr. Leedman co-founded Enigma Therapeutics which listed on the ASX in 2013 as OncoSil Medical Limited.

Mr. Leedman previously served for 10 years as Vice President, Investor Relations for pSivida Corp. which is listed on the ASX and NASDAQ.

To view the full announcement, please click on the button below.

Capital Insights
The Index Approach in Early-Stage Venture Capital: Reconsidered

The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]

Capital Insights
The Future Is Now: The Evolution of Dealflow with Wholesale Investor

If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]

Join over 45,000+ sophisticated investors

Join Now